Oligonucleotide Synthesis Market Size, Share, Growth Report 2030

The report covers a forecast and an analysis of the oligonucleotide synthesis market on a global and regional level. The study provides historical data for 2016 and 2017 along with a forecast from 2019 to 2026 based on revenue (USD Million). The study includes the drivers and restraints of the oligonucleotide synthesis market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the oligonucleotide synthesis market on a global level.

In order to give the users of this report a comprehensive view of the oligonucleotide synthesis market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research& development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the oligonucleotide synthesis market by segmenting the market based on offering, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2026. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries.

Some leading players of the global oligonucleotide synthesis market include ATD Bio Ltd., BianoScience GmbH, BioSpring GmbH, Bioneer Corporation, Bio-Synthesis, Inc., Creative Biogene, Dalton Pharma Services, Eurofins Genomics, GE, GeneDesign, Inc., GenScript, IBA GmbH, Integrated DNA Technologies, Inc., Kaneka Eurogentec S.A., LGC Biosearch Technologies, Merck KGaA, Microsynth AG, Syngene, Thermo Fisher Scientific, Inc., TriLink BioTechnologies, LLC, and Twist Bioscience.

This report segments the global oligonucleotide synthesis market into:

Global Oligonucleotide Synthesis Market: Offering Analysis

• Equipment
• Reagents and Consumables
• Synthesized Oligonucleotides
  • By Product
    • Primers
    • Probes
    • Large-Scale Synthesis Oligonucleotides
    • Intermediate-Scale Synthesis Oligonucleotides
    • Linkers and Adaptors
    • Others
  • By Service
    • Custom/Specialty Oligonucleotides
      • Modified
      • Non-Modified
    • Pre-Designed Oligonucleotides

Global Oligonucleotide Synthesis Market: Application Analysis

• Research
  • Polymerase Chain Reaction
  • qPCR
  • Next Generation Sequencing
  • Others
• Therapeutics
  • Antisense Oligonucleotides
  • RNAi
  • Nucleic Acid Aptamers
  • Immunotherapy Applications
• Diagnostics

Global Oligonucleotide Synthesis Market: End-User Analysis

• Academic Research Institutes
• Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Others

Global Oligonucleotide Synthesis Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa